Vascular Ehlers–Danlos syndrome: A multidisciplinary clinical framework for early suspicion, emergency‐safe management and lifelong care
Journal of Internal Medicine · 2026-12 · 300 (6) · 743-757
DOI: 10.1111/joim.70165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Internal Medicine, online erschienen am 25.09.2026. Verfasst von Salvatore Corrao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Internal Medicine Unit (with Rheumatology, Dermatology, Diabetology and Tertiary Diabetic-Foot Care), ARNAS Civico, …. Hauptthemen laut MEDLINE: Ehlers-Danlos Syndrome, Type IV, Ehlers-Danlos Syndrome. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Vascular Ehlers–Danlos syndrome (vEDS), caused by likely pathogenic COL3A1 variants, carries a high risk of arterial dissection or rupture, intestinal perforation and uterine rupture, and a median survival near 51 years. It is often recognized only at a catastrophe, and its acute management is deliberately counter‐intuitive. The therapeutic landscape changed in 2025 with the first randomized evidence for an angiotensin‐receptor blocker. We provide a clinical, practice‐oriented review for internists and the multidisciplinary team. As is appropriate for a rare disease, case‐level evidence was considered alongside cohorts and trials. Suspicion is the rate‐limiting step, and we set out speciality‐specific red flags. Diagnosis requires molecular confirmation, with differentiation from other heritable arteriopathies. Genotype is a probabilistic predisposition, not a deterministic predictor: there is ascertainment bias, reduced penetrance and intrafamilial variability temper inference. Emergency care is harm‐avoidant—catheter angiography, elective endoscopy and unnecessary surgery should be avoided, and endovascular and tissue‐sparing techniques preferred. Pharmacological prevention rests on celiprolol, with randomized evidence now supporting irbesartan added to background celiprolol, and expert‐centred consideration of angiotensin‐receptor blockade when celiprolol is not tolerated. Surveillance should be individualized along the European Reference Network on Rare Multisystemic Vascular Diseases logic. Pregnancy, psychosocial care and cascade testing complete lifelong management. In vEDS, earlier recognition and the avoidance of iatrogenic harm—not new molecules—offer the largest near‐term gains in survival and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Internal Medicine Unit (with Rheumatology, Dermatology, Diabetology and Tertiary Diabetic-Foot Care), ARNAS Civico, Di Cristina, Benfratelli, Palermo, Italy.
- Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.
- Department of Internal Medicine, Azienda Ospedaliera Universitaria "Policlinico G. Martino", University of Messina, Messina, Italy.
- Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), Palermo, Italy.
ORCID-Profile: Salvatore Corrao, Giacomo Corrao, Luigi Calvo, Salvatore Scibetta
Zitieren
APA
Corrao, S., Ruggeri, M. I., Benedetto, A. D., Corrao, G., Calvo, L., & Scibetta, S. (2026). Vascular Ehlers–Danlos syndrome: A multidisciplinary clinical framework for early suspicion, emergency‐safe management and lifelong care. Journal of Internal Medicine, 300(6), 743-757. https://doi.org/10.1111/joim.70165
Vancouver
Corrao S, Ruggeri MI, Benedetto AD, Corrao G, Calvo L, Scibetta S. Vascular Ehlers–Danlos syndrome: A multidisciplinary clinical framework for early suspicion, emergency‐safe management and lifelong care. Journal of Internal Medicine. 2026;300(6):743-757. doi:10.1111/joim.70165
BibTeX
@article{Corrao2026,
author = {Corrao, Salvatore and Ruggeri, Maria Irene and Benedetto, Antonino Di and Corrao, Giacomo and Calvo, Luigi and Scibetta, Salvatore},
title = {Vascular Ehlers–Danlos syndrome: A multidisciplinary clinical framework for early suspicion, emergency‐safe management and lifelong care},
journal = {Journal of Internal Medicine},
year = {2026},
volume = {300},
number = {6},
pages = {743--757},
doi = {10.1111/joim.70165}
}
EUVIMED